2seventy bio, Inc. (TSVT) Financials
TSVT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 565.4 million | 310.1 million |
2023-09-30 | 640.8 million | 334.4 million |
2023-06-30 | 705.7 million | 338.2 million |
2023-03-31 | 742.4 million | 341.1 million |
TSVT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -64.7 million | 5.0 million |
2023-09-30 | -24.3 million | 9.8 million |
2023-06-30 | -36.6 million | 7.7 million |
2023-03-31 | -55.2 million | 9.7 million |
TSVT Net Income
No data available :(
TSVT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 217.0 million | - | 256.7 million |
2023-09-30 | 250.6 million | - | 260.2 million |
2023-06-30 | 282.8 million | - | 263.6 million |
2023-03-31 | 339.9 million | - | 267.0 million |
TSVT Shares Outstanding
TSVT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.1 million | 48.2 million | 16.2 million | - |
2023-09-30 | 2.7 million | 51.3 million | 13.0 million | - |
2023-06-30 | 4.0 million | 60.0 million | 19.5 million | - |
2023-03-31 | 6.1 million | 68.2 million | 20.8 million | - |
TSVT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 10.7 million | 6.2 million |
2023-09-30 | 12.0 million | 5.0 million |
2023-06-30 | 36.0 million | 4.5 million |
2023-03-31 | 41.6 million | 4.3 million |
TSVT
Price: $4.59
52 week price:
Earnings Per Share: -4.42 USD
P/E Ratio: -1.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 673900
Market Capitalization: 252.5 million